‌

US Patent 8852623 Implantable polymeric device for sustained release of dopamine agonist

Patent 8852623 was granted and assigned to Titan Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Titan Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8852623

Date of Patent

October 7, 2014

Patent Application Number

13525193

Date Filed

June 15, 2012

Patent Citations Received

‌

US Patent 11690806 Implantable device for sustained release of a macromolecular drug compound

‌

US Patent 12108225 Implantable device for sustained release of a macromolecular drug compound

‌

US Patent 11951215 Implantable device for sustained release of a macromolecular drug compound

‌

US Patent 11690807 Implantable device for sustained release of a macromolecular drug compound

Patent Primary Examiner

‌

Jake Vu

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8852623 Implantable polymeric device for sustained release of dopamine agonist

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API